Evidence map›Paper›PMID 40212298›Full record

ArticleSmall science2023

Advances of Single-Atomic Cobalt Catalysts in Liquid-Phase Selective Oxidative Reactions.

Jiaquan Li, Kai Wang, Yijiao Jiang, Jun Huang, Shaomin Liu

Abstract read
In one paragraph

Article in Small science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiaquan LiSchool of Chemical and Biomolecular Engineering Sydney Nano Institute The University of Sydney Sydney NSW 2037 Australia.
Kai WangWA School of Mines: Minerals, Energy and Chemical Engineering Curtin University Perth WA 6102 Australia.
Yijiao JiangDepartment of Engineering Macquarie University Sydney NSW 2109 Australia.
Jun HuangSchool of Chemical and Biomolecular Engineering Sydney Nano Institute The University of Sydney Sydney NSW 2037 Australia.
Shaomin LiuWA School of Mines: Minerals, Energy and Chemical Engineering Curtin University Perth WA 6102 Australia.ORCID 0000-0001-5019-5182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-atom catalysts (SACs) composed of atomically dispersed metal-active sites embedded in supporting substrates are attracting increasing attention in liquid-phase selective oxidation reactions with joint merits of both advanced catalytic efficiency and high stability. Co-based SACs present superior performance in several model oxidative reactions against many other metals, thus they are recognized as a promising solution to the current high-cost noble-metal catalysts required for the synthesis of fine chemicals. In this review, the up-to-date research on the synthesized Co-SACs in selective oxidation applications is summarized. The strategies of the preparation of Co-SACs with diverse Co-loading levels and well-tuned morphologies and chemical structures are showcased, as well as the characterization techniques of the SACs. The applications of Co-SACs in a series of selective oxidation reactions and the influence of different oxidants on the overall reaction efficiency are discussed. In addition, the progress of the mechanism exploration involving active-site identification, catalytic activation of oxidants, and oxidation pathway elucidation is highlighted. Meanwhile, the existing challenges and the future efforts for the development of the Co-SAC reaction system in selective oxidation processes are outlined.

Indexed as

cobaltoxidantsreaction mechanismselective oxidationsingle-atom catalysts

Identifiers

PMID40212298
PMCPMC11935984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.